OncologyPublished on September 8, 2026•7 min readClinically Reviewed

CyberKnife vs. Conventional Radiation Therapy for Solid Tumors

Dr. Elena Rodriguez

Dr. Elena Rodriguez

Chief Medical Liaison & Patient Safety Officer

Key Clinical Takeaways
  • CyberKnife tracks tumor motion in real-time, synchronizing with the patient's breathing cycle.
  • Treatment is completed in 1 to 5 outpatient sessions instead of 30 to 45 daily visits required for traditional radiation.
  • Sub-millimeter beam targeting drastically minimizes collateral radiation to surrounding healthy tissue.
  • Zero recovery downtime: patients resume light everyday activities immediately following each session.
Radiation therapy has undergone a transformative revolution with the advent of Stereotactic Radiosurgery (SRS) and the CyberKnife System. For patients with inoperable or complex tumors in the brain, spine, lung, liver, or prostate, this non-invasive approach provides surgical-grade tumor ablation without anesthesia, scalpel cuts, or blood loss.

How Real-Time AI Tracking Eliminates Invasiveness

Conventional stereotactic brain surgery traditionally required bolting an uncomfortable metal stereotactic frame directly onto the patient's skull. CyberKnife replaces this with advanced real-time digital X-ray tracking and an articulated robotic arm capable of firing beams from over 1,200 angles with sub-millimeter pinpoint accuracy.

Available Oncology Super-Centers in India

Our empanelled partner institutions—including Apollo Proton Cancer Centre and Fortis Memorial Research Institute—house latest-generation CyberKnife M6 and TrueBeam STx systems, overseen by tumor boards collaborating directly with global oncologists.

Have questions about your treatment options?

Our medical team evaluates medical records within 24 hours at zero cost.

Request Case Assessment

Join Our Community of Healthy Patients

Ready to experience the future of healthcare? Book your initial consultation with one of our world-class specialists today.